Optiscan Imaging has strengthened its mission aimed at breaking into the United States health market with its “ViewnVivo” technology by...

Optiscan Imaging is on a mission to prove its groundbreaking technology can provide surgeons with the exact extent of breast cancer...

Optiscan Imaging has rounded out a dynamic year with a whopping 66 per cent revenue boost to nearly $1.7 million following the sale of...

Optiscan Imaging has ticked off a major milestone in developing its telepathology platform with the project passing its proof-of-concept...

Optiscan Imaging says it has successfully raised $16.7 million from a recent entitlement issue as the company looks to pursue research...

ASX-listed Optiscan Imaging has been invited to present its remarkable confocal endomicroscopic medical imaging technology at two key...

ASX-listed Optiscan Imaging is ramping up its bid to pioneer a new standard of care in digital pathology and precision surgery, with its...